Acorda Therapeutics Inc (ACORQ)
0.605
+0.10
(+18.63%)
USD |
OTCM |
May 17, 16:00
Acorda Therapeutics Accounts Receivable (Quarterly): 9.188M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 9.188M |
December 31, 2023 | 17.30M |
September 30, 2023 | 11.98M |
June 30, 2023 | 13.39M |
March 31, 2023 | 9.19M |
December 31, 2022 | 13.87M |
September 30, 2022 | 14.69M |
June 30, 2022 | 14.27M |
March 31, 2022 | 11.99M |
December 31, 2021 | 17.00M |
September 30, 2021 | 13.59M |
June 30, 2021 | 14.01M |
March 31, 2021 | 17.30M |
December 31, 2020 | 20.19M |
September 30, 2020 | 13.38M |
June 30, 2020 | 14.77M |
March 31, 2020 | 14.97M |
December 31, 2019 | 22.08M |
September 30, 2019 | 17.55M |
June 30, 2019 | 21.01M |
March 31, 2019 | 20.65M |
December 31, 2018 | 23.43M |
September 30, 2018 | 51.46M |
June 30, 2018 | 64.36M |
March 31, 2018 | 50.79M |
Date | Value |
---|---|
December 31, 2017 | 81.40M |
September 30, 2017 | 53.82M |
June 30, 2017 | 55.63M |
March 31, 2017 | 50.24M |
December 31, 2016 | 52.24M |
September 30, 2016 | 48.58M |
June 30, 2016 | 45.89M |
March 31, 2016 | 41.62M |
December 31, 2015 | 31.47M |
September 30, 2015 | 31.76M |
June 30, 2015 | 29.80M |
March 31, 2015 | 30.55M |
December 31, 2014 | 32.21M |
September 30, 2014 | 24.79M |
June 30, 2014 | 27.03M |
March 31, 2014 | 29.26M |
December 31, 2013 | 30.78M |
September 30, 2013 | 25.00M |
June 30, 2013 | 27.06M |
March 31, 2013 | 23.29M |
December 31, 2012 | 26.33M |
September 30, 2012 | 23.23M |
June 30, 2012 | 23.61M |
March 31, 2012 | 21.53M |
December 31, 2011 | 22.83M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
9.188M
Minimum
Mar 2024
22.08M
Maximum
Dec 2019
15.09M
Average
14.48M
Median
Accounts Receivable (Quarterly) Benchmarks
BioSig Technologies Inc | 0.024M |
Verve Therapeutics Inc | -- |
Spectral AI Inc | 1.312M |
AIM ImmunoTech Inc | -- |
Protalix BioTherapeutics Inc | 3.759M |